Leptomeningeal metastasis from solid tumors: A single center experience in Chinese patients

Journal of Neuro-Oncology

Volumn 115, Issue 2, 2013, Pages 285-291

  Du, Chunxia ^a   Hong, Ruoxi ^a   Shi, Yuankai ^a   Yu, Xiaoduo ^a   Wang, Jinwan ^a  

^a PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

EGFR TKI; KPS; Leptomeningeal metastasis; Radiotherapy; Systemic treatment

Indexed keywords

CAPECITABINE; CYTARABINE; DOCETAXEL; ERLOTINIB; GEFITINIB; IRINOTECAN; METHOTREXATE; PACLITAXEL; PEMETREXED; PLATINUM COMPLEX; PROTEIN TYROSINE KINASE INHIBITOR; TEMOZOLOMIDE; TENIPOSIDE; TOPOTECAN; TRASTUZUMAB;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CHINESE; CLINICAL ARTICLE; FEMALE; HUMAN; KARNOFSKY PERFORMANCE STATUS; LEPTOMENINGEAL METASTASIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; RETROSPECTIVE STUDY; SOLID TUMOR; STOMACH CANCER; SURVIVAL RATE; SURVIVAL TIME; WHOLE BRAIN RADIOTHERAPY;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; CHEMORADIOTHERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84886591322     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1228-x     Document Type: Article

References (21)

1. Chamberlain MC (2010) Leptomeningeal metastasis. Semin Neurol 30:236-244
2. Taillibert S, Laigle-Donadey F, Chodkiewicz C et al (2005) Leptomeningeal metastases from solid malignancy: a review. J Neurooncol 75:85-99
3. Kaplan JG, DeSouza TG, Farkash A et al (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9:225-229
4. Glass JP, Melamed M, Chernik NL et al (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369-1375
5. Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759-772
6. Straathof CS, de Bruin HG, Dippel DW et al (1999) The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 246:810-814
7. Singh SK, Leeds NE, Ginsberg LE (2002) MR imaging of leptomeningeal metastases: comparison of three sequences. AJNR Am J Neuroradiol 23:817-821
8. Clarke JL, Perez HR, Jacks LM et al (2010) Leptomeningeal metastases in the MRI era. Neurology 74:1449-1454
9. Herrlinger U, Forschler H, Kuker W et al (2004) Leptomeningeal metastasis: survival and prognostic factors in 155 patients. J Neurol Sci 223:167-178
10. Oechsle K, Lange-Brock V, Kruell A et al (2010) Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis. J Cancer Res Clin Oncol 136:1729-1735
11. Waki F, Ando M, Takashima A et al (2009) Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93:205-212
12. Yi HG, Kim HJ, Kim YJ et al (2009) Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI. Lung Cancer 65:80-84
13. Umemura S, Tsubouchi K, Yoshioka H et al (2012) Clinical outcome in patients with leptomeningeal metastasis from non-small cell lung cancer: okayama Lung Cancer Study Group. Lung Cancer 77:134-139
14. Oliveira M, Braga S, Passos-Coelho JL et al (2011) Complete response in HER2 + leptomeningeal carcinomatosis from breast cancer with intrathecal trastuzumab. Breast Cancer Res Treat 127:841-844
15. Fukuhara T, Saijo Y, Sakakibara T et al (2008) Successful treatment of carcinomatous meningitis with gefitinib in a patient with lung adenocarcinoma harboring a mutated EGF receptor gene. Tohoku J Exp Med 214:359-363
16. Shigekawa T, Takeuchi H, Misumi M et al (2009) Successful treatment of leptomeningeal metastases from breast cancer using the combination of trastuzumab and capecitabine: a case report. Breast Cancer 16:88-92
17. Chamberlain MC (1998) Leptomeningeal metastases: a review of evaluation and treatment. J Neurooncol 37:271-284
18. Groves MD (2010) New strategies in the management of leptomeningeal metastases. Arch Neurol 67:305-312
19. Morris PG, Reiner AS, Szenberg OR et al (2012) Leptomeningeal metastasis from non-small cell lung cancer: survival and the impact of whole brain radiotherapy. J Thorac Oncol 7:382-385
20. Sosman JA, Kim KB, Schuchter L et al (2012) Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. N Engl J Med 366:707-714
21. Schäfer N, Scheffler B, Stuplich M et al (2013) Vemurafenib for leptomeningeal melanomatosis. J Clin Oncol 31:e173-e174